HEAL Stock Overview
Operates a network of general hospitals in Indonesia. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 1/6 |
PT Medikaloka Hermina Tbk Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Rp1,360.00 |
| 52 Week High | Rp1,640.00 |
| 52 Week Low | Rp1,060.00 |
| Beta | 0.48 |
| 11 Month Change | -8.72% |
| 3 Month Change | 5.02% |
| 1 Year Change | -9.33% |
| 33 Year Change | 37.37% |
| 5 Year Change | 85.29% |
| Change since IPO | 114.51% |
Recent News & Updates
Recent updates
Shareholder Returns
| HEAL | ID Healthcare | ID Market | |
|---|---|---|---|
| 7D | 1.9% | -3.1% | -2.2% |
| 1Y | -9.3% | 19.3% | 9.3% |
Return vs Industry: HEAL underperformed the ID Healthcare industry which returned 19.9% over the past year.
Return vs Market: HEAL underperformed the ID Market which returned 8.2% over the past year.
Price Volatility
| HEAL volatility | |
|---|---|
| HEAL Average Weekly Movement | 3.9% |
| Healthcare Industry Average Movement | 5.8% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in ID Market | 12.6% |
| 10% least volatile stocks in ID Market | 2.4% |
Stable Share Price: HEAL has not had significant price volatility in the past 3 months compared to the ID market.
Volatility Over Time: HEAL's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 18,231 | H. Hasmoro | www.herminahospitals.com |
PT Medikaloka Hermina Tbk operates a network of general hospitals in Indonesia. It is also involved in the investment, service, and trading business activities. The company was founded in 1985 and is based in Jakarta, Indonesia.
PT Medikaloka Hermina Tbk Fundamentals Summary
| HEAL fundamental statistics | |
|---|---|
| Market cap | Rp20.25t |
| Earnings (TTM) | Rp556.67b |
| Revenue (TTM) | Rp6.58t |
36.4x
P/E Ratio3.1x
P/S RatioIs HEAL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HEAL income statement (TTM) | |
|---|---|
| Revenue | Rp6.58t |
| Cost of Revenue | Rp4.31t |
| Gross Profit | Rp2.27t |
| Other Expenses | Rp1.72t |
| Earnings | Rp556.67b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 37.39 |
| Gross Margin | 34.56% |
| Net Profit Margin | 8.46% |
| Debt/Equity Ratio | 52.3% |
How did HEAL perform over the long term?
See historical performance and comparison